LifeStance Health Group, Inc. (LFST) Misses Q3 EPS by 10c

LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q3 EPS of ($0.17), $0.10 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $262.9 million versus the consensus estimate of $255.18 million.

For earnings history and earnings-related data on LifeStance Health Group, Inc. (LFST) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
• GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'